BIOMERIEUX (EPA:BIM) | WebDisclosure

Basculer en Français

11293	Companies
250965	Keywords
179876	Articles
136831	Press releases

Home
Companies
BIOMERIEUX

BRIEF

published on 11/03/2026 at 07:05, 4 days 2 hours ago

BioMérieux affiche une solide croissance au 3e trimestre 2026

BioMérieux Croissance Organique GO•28 Diagnostic Délocalisé Innovatons 2026
BRIEF

published on 11/03/2026 at 07:05, 4 days 2 hours ago

BioMérieux Reports Solid Third-Quarter 2026 Performance with Continued Growth

BioMérieux Organic Growth SPOTFIRE Q3 2026 BIOFIRE Panels
REGULATED PRESS RELEASE

published on 11/03/2026 at 07:00, 4 days 2 hours ago

bioMérieux – Information financière du 3ème trimestre 2026
REGULATED PRESS RELEASE

published on 11/03/2026 at 07:00, 4 days 2 hours ago

bioMérieux – Third-Quarter 2026 Business Review
BRIEF

published on 11/02/2026 at 08:45, 5 days 1 hour ago

BioMérieux : Déclaration du Capital Social et Droits de Vote en Octobre 2026

Droits De Vote Capital Social BioMérieux Actions Transparence Financière
BRIEF

published on 11/02/2026 at 08:45, 5 days 1 hour ago

BioMérieux: Declaration of Share Capital and Voting Rights in October 2026

Share Capital Voting Rights BioMérieux Actions Financial Transparency
REGULATED PRESS RELEASE

published on 11/02/2026 at 08:40, 5 days 1 hour ago

Octobre 2026 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
BRIEF

published on 10/22/2026 at 18:05, 15 days 15 hours ago

BioMérieux Achieves FDA Clearance for Rapid Vaginitis Diagnostic Panel

FDA Clearance Molecular Diagnostics Women's Health Rapid Testing Vaginitis
BRIEF

published on 10/22/2026 at 18:05, 15 days 15 hours ago

BioMérieux reçoit l'approbation de la FDA pour le BIOFIRE® SPOTFIRE® Vaginitis Panel

FDA BioMérieux Santé Des Femmes Diagnostic Rapide Vaginite
REGULATED PRESS RELEASE

published on 10/22/2026 at 18:00, 15 days 15 hours ago

bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel, advancing women’s health with rapid molecular diagnostics

BioMérieux BIOFIRE® SPOTFIRE® Dual 510(k) Clearance CLIA Waiver Vaginitis Panel

Accesswire

Published on 11/06/2026 at 22:15, 11 hours 43 minutes ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 20 hours 58 minutes ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 21 hours 28 minutes ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 21 hours 28 minutes ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 23 hours 58 minutes ago

Mongolia Tax Audit

View all ACCESSWIRE

EQS Group

Published on 11/06/2026 at 20:15, 13 hours 43 minutes ago

African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 13 hours 43 minutes ago

L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:15, 14 hours 43 minutes ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 14 hours 58 minutes ago

Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 15 hours 26 minutes ago

EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond

Les Echos

Published on 11/06/2026 at 19:06, 14 hours 52 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 14 hours 54 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 14 hours 56 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 14 hours 58 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 18:00, 15 hours 58 minutes ago

ICADE - CP - Notation crédit S&P

View all LES ECHOS COMFI WIRE